FLT3LG
protein-codingfms related receptor tyrosine kinase 3 ligand, the group of Receptor ligands
Gene summary
Dendritic cells (DCs) provide the key link between innate and adaptive immunity by recognizing pathogens and priming pathogen-specific immune responses. FLT3LG controls the development of DCs and is particularly important for plasmacytoid DCs and CD8 (see MIM 186910)-positive classical DCs and their CD103 (ITGAE; MIM 604682)-positive tissue counterparts (summary by Sathaliyawala et al., 2010 [PubMed 20933441]).[supplied by OMIM, Jan 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~12.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0975749
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Gastrointestinal
Intervention: Allergy/Immunology/Infectious
Rationale: The condition can include recurrent infections, and awareness may allow preventive measures and early and aggressive treatment of infections
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FLT3LG variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001459.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | ||||
| missense | 31 | 3 | 34 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 1 | 0 | 34 | 3 | 1 | 39 |
Highest pathogenic variant AF is 0.00019413354
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001450.2 | 7 | MANE Select | |
| Ensembl | ENSP00000468977.1 | 7 | MANE Select | |
| RefSeq | NP_001191431.1 | 7 | Standard | |
| RefSeq | NP_001191432.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- PI3K-Akt signaling pathway - Homo sapiens (human)
- Ras signaling pathway - Homo sapiens (human)
- MAPK signaling pathway - Homo sapiens (human)
- Pathways in cancer - Homo sapiens (human)
- Hematopoietic cell lineage - Homo sapiens (human)
Biological Process
- MAPK cascade
- positive regulation of protein phosphorylation
- signal transduction
- positive regulation of cell population proliferation
- regulation of signaling receptor activity
Molecular Function
- Ras guanyl-nucleotide exchange factor activity
- signaling receptor binding
- cytokine activity
- 1-phosphatidylinositol-3-kinase activity
- receptor tyrosine kinase binding
Cellular Component
- extracellular region
- extracellular space
- cell surface
- membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000594009
- Coding exons
- 7
- Length
- 12025
- Individuals with no LoFs
- 124183
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 3
- Defined
- 124186
- p
- 0.0000121
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.897 | 108 | 138 | 0.785 | 0.00000832 | 1462 |
| Missense (PolyPhen) | 7 | 14.105 | 0.49627 | 149 | ||
| Synonymous | 0.570 | 56 | 61.7 | 0.908 | 0.00000351 | 518 |
| Loss of Function | 3.13 | 1 | 13.3 | 0.0750 | 6.44e-7 | 136 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000038 | 0.000027 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Stimulates the proliferation of early hematopoietic cells by activating FLT3. Synergizes well with a number of other colony stimulating factors and interleukins.;
Recessive Scores
- pRec
- 0.143
Intolerance Scores
- LoFtool
- 0.109
- RVIS EVS
- -0.56
- RVIS percentile EVS
- 19.31
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.439
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |